Press Releases - 2021-06-15

Date	Title	Company
15-Jun-2021	AMCOR LAUNCHES NEW DUAL CHAMBER POUCH FOR DRUG COMBINATION DEVICES IN EUROPE	Amcor
15-Jun-2021	New results from AlzeCure’s pain project TrkA-NAM presented at the IASP pain conference	AlzeCure Pharma AB
15-Jun-2021	Evotec SE virtual Annual General Meeting 2021 approves all proposed agenda items	Evotec SE
15-Jun-2021	London Ambulance Service medics recognised in Queen’s Birthday Honours	London Ambulance Service
15-Jun-2021	Novartis investigational oral therapy iptacopan (LNP023) shows benefit as monotherapy in treatment-naïve patients with rare and life-threatening blood disorder paroxysmal nocturnal hemoglobinuria	Novartis
15-Jun-2021	New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor with the potential to be the first approved treatment for hemolysis in people with cold agglutinin disease, a serious and chronic autoimmune hemolytic anemia	Sanofi
15-Jun-2021	Bright Peak Therapeutics gibt Serie-B-Finanzierungsrunde in Höhe von 107 Millionen US-Dollar und Erweiterung des Vorstands bekannt	Bright Peak Therapeutics
15-Jun-2021	Further Subscription to raise £1,470,000 to progress proprietary TYK2/JAK1 programmes into clinical development	Sareum Holdings plc
15-Jun-2021	NHS Business Services Authority achieves gold standard in information security management by British Standards	NHS Business Services Authority
15-Jun-2021	Hertility Health pulls in £4.2M in Seed funding as it sets eyes on becoming the UK’s leading ‘home for women’s health’	Hertility Health
15-Jun-2021	Scientists develop ‘game-changing’ antibody test	University of Aberdeen
15-Jun-2021	ClinSpec Diagnostics rebrands as Dxcover and targets growth	Dxcover Limited
15-Jun-2021	Novo Holdings acquires BBI Group	Novo Holdings
15-Jun-2021	Actimed Therapeutics to Present at BioTrinity 2021	Actimed Therapeutics
15-Jun-2021	GENinCode announces major US commercialisation partnership with EVERSANA	GENinCode UK Limited
15-Jun-2021	GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK	Global Blood Therapeutics, Inc.
15-Jun-2021	Domainex wins Best CRO at OBN Awards	Domainex
15-Jun-2021	Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment	Celltrion
15-Jun-2021	RANDOX HEALTH AND TEAM GB SIGN 2-YEAR COVID TESTING PARTNERSHIP	RANDOX HEALTH
15-Jun-2021	OBN Awards 2020 – Winners Recognised at the Life Sciences Industry’s First In-Person Event of 2021	OBN (UK) Ltd